BRIEF published on 12/06/2024 at 07:05, 1 year 5 months ago Innate Pharma: Investment of 7.9 million dollars for IPH6501 Investment Clinical Trial Innate Pharma IPH6501 Follicular Lymphoma
PRESS RELEASE published on 12/06/2024 at 07:00, 1 year 5 months ago Informations privilégiées / Autres communiqués Innate Pharma et l'Institut d'Innovation pour le Lymphome Folliculaire (IFLI) signent un accord d'investissement jusqu'à 7,9 millions de dollars pour le développement d'IPH6501 dans le lymphome folliculaire Investissement Innate Pharma Lymphome Folliculaire IPH6501 IFLI
BRIEF published on 11/20/2024 at 07:05, 1 year 5 months ago Innate Pharma dévoile son calendrier financier pour 2025 Résultats Annuels Innate Pharma Calendrier Financier 2025 Assemblées Et Publications Cotisation Euronext Et Nasdaq
BRIEF published on 11/20/2024 at 07:05, 1 year 5 months ago Innate Pharma unveils its financial calendar for 2025 Annual Results Innate Pharma Financial Calendar 2025 Assemblies And Publications Euronext And Nasdaq Contribution
PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 5 months ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2025 incluant les dates de publication des résultats et de l'assemblée générale, visant à informer les investisseurs et actionnaires Immunothérapie Événements Financiers Innate Pharma Biotechnologies Calendrier Financier 2025
PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 5 months ago Inside Information / Other news releases Innate Pharma releases its 2025 financial calendar including key publication dates for financial statements and shareholder meetings Financial Statements Investors Financial Calendar 2025 Innate Pharma
BRIEF published on 11/08/2024 at 07:05, 1 year 6 months ago Innate Pharma présente ses innovations en oncologie au SITC 2024 Immunothérapie Innate Pharma NK Cell Engager SITC 2024 Conjugué Anticorps-médicament
BRIEF published on 11/08/2024 at 07:05, 1 year 6 months ago Innate Pharma presents its innovations in oncology at SITC 2024 Immunotherapy Innate Pharma SITC 2024 NK Cell Engage Antibody-drug Conjugate
PRESS RELEASE published on 11/08/2024 at 07:00, 1 year 6 months ago Informations privilégiées / Autres communiqués Annonce de Innate Pharma sur les présentations de données de son portefeuille innovant en oncologie sélectionnées pour le congrès annuel du SITC 2024 Immunothérapie Oncologie ADC Innate Pharma SITC 2024
PRESS RELEASE published on 11/08/2024 at 07:00, 1 year 6 months ago Inside Information / Other news releases Innate Pharma announces new preclinical data on IPH6501 and IPH4502 to be presented at SITC Annual Meeting 2024. Advances in immunotherapy reflected in drug development progress Drug Development Preclinical Data Immunotherapy Innate Pharma SITC Annual Meeting 2024
Published on 05/11/2026 at 19:55, 2 hours 45 minutes ago Lithium South Announces Pay Out of Common Shares and Closing of Plan of Arrangement
Published on 05/11/2026 at 19:30, 3 hours 10 minutes ago Taranis Adjusts Thor Exploration Program Due to Current Political and Regulatory Conditions in British Columbia
Published on 05/11/2026 at 14:30, 8 hours 10 minutes ago Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 8 hours 40 minutes ago Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 14:00, 8 hours 40 minutes ago New Horizon Aircraft Ltd. Announces Closing of $20 Million Offering of Common Shares
Published on 05/11/2026 at 22:05, 35 minutes ago Abivax annonce les résultats de son Assemblée Générale du 11 mai 2026
Published on 05/11/2026 at 22:05, 35 minutes ago Abivax Announces Results of its May 11, 2026 Annual General Meeting
Published on 05/11/2026 at 21:16, 1 hour 23 minutes ago Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 20:42, 1 hour 57 minutes ago Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 20:40, 2 hours ago EQS-Adhoc: Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 19:02, 3 hours 37 minutes ago 260511 BENETEAU Transactions sur actions propres
Published on 05/11/2026 at 18:18, 4 hours 22 minutes ago Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 4 hours 22 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 4 hours 25 minutes ago Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 4 hours 25 minutes ago Number of shares and voting rights - April 2026 (In French only)
